Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultrasonography | 12 | 2023 | 350 | 2.970 |
Why?
|
| Diaphragm | 6 | 2023 | 46 | 2.880 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 7 | 2022 | 32 | 2.570 |
Why?
|
| Critical Care | 9 | 2023 | 115 | 2.160 |
Why?
|
| Coma | 4 | 2018 | 6 | 1.400 |
Why?
|
| Neurology | 3 | 2020 | 45 | 1.400 |
Why?
|
| Status Epilepticus | 3 | 2020 | 22 | 1.280 |
Why?
|
| Brain Injuries | 3 | 2023 | 94 | 1.210 |
Why?
|
| Humans | 40 | 2023 | 29553 | 0.920 |
Why?
|
| Nervous System Diseases | 3 | 2020 | 37 | 0.910 |
Why?
|
| Vascular Resistance | 2 | 2020 | 28 | 0.890 |
Why?
|
| Ventilator Weaning | 1 | 2023 | 4 | 0.890 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2022 | 1225 | 0.850 |
Why?
|
| Journal Impact Factor | 1 | 2022 | 9 | 0.830 |
Why?
|
| Blood Flow Velocity | 3 | 2020 | 59 | 0.800 |
Why?
|
| Intracranial Pressure | 3 | 2022 | 19 | 0.790 |
Why?
|
| Neurosurgery | 1 | 2021 | 34 | 0.760 |
Why?
|
| Endocarditis | 1 | 2020 | 11 | 0.730 |
Why?
|
| Intracranial Embolism | 1 | 2020 | 13 | 0.730 |
Why?
|
| Middle Cerebral Artery | 1 | 2020 | 11 | 0.720 |
Why?
|
| Carotid Arteries | 1 | 2020 | 97 | 0.720 |
Why?
|
| Brain Edema | 1 | 2020 | 16 | 0.720 |
Why?
|
| Carotid Stenosis | 1 | 2020 | 56 | 0.710 |
Why?
|
| Brain | 4 | 2022 | 933 | 0.710 |
Why?
|
| Spinal Puncture | 1 | 2019 | 20 | 0.710 |
Why?
|
| Blood Coagulation Disorders | 1 | 2019 | 9 | 0.700 |
Why?
|
| Lumbar Vertebrae | 1 | 2019 | 99 | 0.670 |
Why?
|
| Renal Dialysis | 2 | 2020 | 265 | 0.660 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 72 | 0.660 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 77 | 0.660 |
Why?
|
| Education, Medical | 1 | 2019 | 68 | 0.650 |
Why?
|
| Respiratory Distress Syndrome, Adult | 2 | 2016 | 55 | 0.650 |
Why?
|
| Respiratory Paralysis | 2 | 2015 | 5 | 0.640 |
Why?
|
| Cerebrovascular Circulation | 5 | 2023 | 95 | 0.640 |
Why?
|
| Life Support Care | 1 | 2017 | 15 | 0.610 |
Why?
|
| Electromyography | 2 | 2015 | 58 | 0.610 |
Why?
|
| Intensive Care Units | 7 | 2021 | 120 | 0.600 |
Why?
|
| Clinical Protocols | 1 | 2017 | 95 | 0.590 |
Why?
|
| Hospitalization | 1 | 2020 | 423 | 0.580 |
Why?
|
| Monitoring, Physiologic | 3 | 2023 | 68 | 0.550 |
Why?
|
| Pentobarbital | 1 | 2016 | 5 | 0.550 |
Why?
|
| Ketamine | 1 | 2016 | 20 | 0.540 |
Why?
|
| Emergency Medical Services | 1 | 2017 | 158 | 0.520 |
Why?
|
| Observer Variation | 1 | 2015 | 96 | 0.510 |
Why?
|
| Kidney Failure, Chronic | 1 | 2020 | 522 | 0.510 |
Why?
|
| Injections, Intramuscular | 1 | 2015 | 42 | 0.510 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2014 | 5 | 0.500 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 376 | 0.490 |
Why?
|
| Muscle, Skeletal | 2 | 2015 | 496 | 0.460 |
Why?
|
| Limbic Encephalitis | 1 | 2013 | 1 | 0.440 |
Why?
|
| Nervous System | 1 | 2013 | 15 | 0.440 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2013 | 13 | 0.440 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2013 | 6 | 0.440 |
Why?
|
| Adult | 10 | 2023 | 8528 | 0.420 |
Why?
|
| Middle Aged | 12 | 2023 | 10936 | 0.390 |
Why?
|
| Critical Illness | 3 | 2023 | 88 | 0.360 |
Why?
|
| Brain Diseases | 2 | 2021 | 40 | 0.350 |
Why?
|
| Ocular Motility Disorders | 2 | 2011 | 5 | 0.350 |
Why?
|
| Muscle Weakness | 2 | 2012 | 39 | 0.340 |
Why?
|
| Pons | 1 | 2008 | 7 | 0.320 |
Why?
|
| Facial Paralysis | 1 | 2008 | 7 | 0.320 |
Why?
|
| Stroke | 3 | 2020 | 552 | 0.320 |
Why?
|
| Aged | 8 | 2023 | 9590 | 0.320 |
Why?
|
| Reproducibility of Results | 2 | 2023 | 727 | 0.300 |
Why?
|
| Male | 13 | 2020 | 18012 | 0.290 |
Why?
|
| Quadriceps Muscle | 2 | 2015 | 31 | 0.260 |
Why?
|
| Retrospective Studies | 4 | 2020 | 3144 | 0.250 |
Why?
|
| Dogs | 2 | 2015 | 117 | 0.250 |
Why?
|
| Female | 11 | 2020 | 18379 | 0.230 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 3764 | 0.220 |
Why?
|
| Echoencephalography | 1 | 2022 | 4 | 0.220 |
Why?
|
| Temporal Bone | 1 | 2022 | 17 | 0.210 |
Why?
|
| Diagnosis, Differential | 3 | 2015 | 493 | 0.210 |
Why?
|
| Psychotropic Drugs | 1 | 2021 | 10 | 0.200 |
Why?
|
| Sensitivity and Specificity | 1 | 2023 | 533 | 0.200 |
Why?
|
| Postoperative Period | 1 | 2021 | 92 | 0.200 |
Why?
|
| Antipsychotic Agents | 1 | 2021 | 26 | 0.200 |
Why?
|
| Neurosurgical Procedures | 1 | 2021 | 98 | 0.190 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2020 | 18 | 0.190 |
Why?
|
| Disease Management | 1 | 2021 | 114 | 0.190 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2020 | 3 | 0.180 |
Why?
|
| Leukoencephalitis, Acute Hemorrhagic | 1 | 2020 | 2 | 0.180 |
Why?
|
| Evidence-Based Practice | 1 | 2020 | 27 | 0.180 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2020 | 9 | 0.180 |
Why?
|
| Cerebral Hemorrhage, Traumatic | 1 | 2020 | 3 | 0.180 |
Why?
|
| Consciousness Disorders | 1 | 2020 | 7 | 0.180 |
Why?
|
| Pulsatile Flow | 1 | 2020 | 25 | 0.180 |
Why?
|
| Hematoma, Subdural, Acute | 1 | 2020 | 7 | 0.180 |
Why?
|
| Vomiting | 1 | 2020 | 24 | 0.180 |
Why?
|
| Palpation | 1 | 2019 | 10 | 0.180 |
Why?
|
| Gels | 1 | 2019 | 33 | 0.180 |
Why?
|
| Blood-Brain Barrier | 1 | 2020 | 43 | 0.180 |
Why?
|
| Cerebrovascular Disorders | 1 | 2020 | 48 | 0.180 |
Why?
|
| Nausea | 1 | 2020 | 49 | 0.180 |
Why?
|
| Models, Anatomic | 1 | 2019 | 38 | 0.170 |
Why?
|
| Headache | 1 | 2020 | 74 | 0.170 |
Why?
|
| Parkinson Disease | 1 | 2020 | 68 | 0.170 |
Why?
|
| Epilepsy | 1 | 2020 | 60 | 0.170 |
Why?
|
| Electroencephalography | 2 | 2018 | 71 | 0.170 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 56 | 0.170 |
Why?
|
| History, 21st Century | 1 | 2019 | 49 | 0.170 |
Why?
|
| History, 20th Century | 1 | 2019 | 69 | 0.170 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 95 | 0.170 |
Why?
|
| Comorbidity | 1 | 2020 | 548 | 0.160 |
Why?
|
| Stupor | 1 | 2018 | 1 | 0.160 |
Why?
|
| Hepatic Encephalopathy | 1 | 2018 | 2 | 0.160 |
Why?
|
| Liver Failure | 1 | 2018 | 17 | 0.160 |
Why?
|
| Subdural Space | 1 | 2017 | 2 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 242 | 0.150 |
Why?
|
| Hematoma, Subdural, Chronic | 1 | 2017 | 4 | 0.150 |
Why?
|
| Seizures | 1 | 2018 | 64 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 874 | 0.150 |
Why?
|
| Dementia | 1 | 2020 | 237 | 0.150 |
Why?
|
| Fibrinolytic Agents | 1 | 2017 | 70 | 0.150 |
Why?
|
| Postoperative Complications | 1 | 2021 | 676 | 0.140 |
Why?
|
| Child | 1 | 2023 | 2233 | 0.140 |
Why?
|
| Anticonvulsants | 2 | 2021 | 63 | 0.140 |
Why?
|
| Midazolam | 1 | 2016 | 11 | 0.140 |
Why?
|
| Physical Therapy Modalities | 1 | 2016 | 60 | 0.140 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 27 | 0.130 |
Why?
|
| Respiration, Artificial | 1 | 2016 | 96 | 0.130 |
Why?
|
| Pilot Projects | 2 | 2014 | 489 | 0.130 |
Why?
|
| Wasting Syndrome | 1 | 2015 | 14 | 0.130 |
Why?
|
| Length of Stay | 1 | 2016 | 296 | 0.130 |
Why?
|
| Muscle Strength | 1 | 2015 | 145 | 0.120 |
Why?
|
| Hyperthyroidism | 1 | 2013 | 3 | 0.120 |
Why?
|
| Gonadotropins | 1 | 2013 | 5 | 0.120 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2013 | 6 | 0.120 |
Why?
|
| Young Adult | 1 | 2020 | 2431 | 0.120 |
Why?
|
| Macaca fascicularis | 1 | 2015 | 389 | 0.110 |
Why?
|
| Veins | 1 | 2013 | 29 | 0.110 |
Why?
|
| Cranial Sinuses | 1 | 2013 | 20 | 0.110 |
Why?
|
| Venous Thrombosis | 1 | 2013 | 49 | 0.110 |
Why?
|
| Intercostal Muscles | 1 | 2013 | 2 | 0.110 |
Why?
|
| Respiratory Muscles | 1 | 2013 | 7 | 0.110 |
Why?
|
| Prions | 1 | 2013 | 3 | 0.110 |
Why?
|
| Autopsy | 1 | 2013 | 38 | 0.110 |
Why?
|
| Animals | 2 | 2015 | 7339 | 0.110 |
Why?
|
| Respiratory Function Tests | 1 | 2013 | 111 | 0.110 |
Why?
|
| Antibodies | 1 | 2013 | 53 | 0.110 |
Why?
|
| Echocardiography | 1 | 2013 | 141 | 0.110 |
Why?
|
| Paraneoplastic Syndromes, Nervous System | 1 | 2011 | 1 | 0.100 |
Why?
|
| Cerebellar Ataxia | 1 | 2011 | 2 | 0.100 |
Why?
|
| Encephalitis | 1 | 2011 | 5 | 0.100 |
Why?
|
| Dietary Supplements | 1 | 2013 | 172 | 0.100 |
Why?
|
| Testicular Neoplasms | 1 | 2011 | 17 | 0.100 |
Why?
|
| Calciphylaxis | 1 | 2011 | 2 | 0.100 |
Why?
|
| Respiratory Insufficiency | 1 | 2012 | 61 | 0.100 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2011 | 56 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 1389 | 0.100 |
Why?
|
| Piracetam | 1 | 2010 | 1 | 0.100 |
Why?
|
| Epilepsy, Generalized | 1 | 2010 | 5 | 0.100 |
Why?
|
| Thrombocytopenia | 1 | 2010 | 32 | 0.090 |
Why?
|
| Metronidazole | 1 | 2010 | 15 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 984 | 0.090 |
Why?
|
| Positron-Emission Tomography | 1 | 2011 | 174 | 0.090 |
Why?
|
| Interprofessional Relations | 1 | 2010 | 48 | 0.090 |
Why?
|
| Patient Transfer | 1 | 2010 | 37 | 0.090 |
Why?
|
| Skin | 1 | 2011 | 205 | 0.090 |
Why?
|
| Continuity of Patient Care | 1 | 2010 | 64 | 0.080 |
Why?
|
| Communication | 1 | 2010 | 124 | 0.080 |
Why?
|
| Basilar Artery | 1 | 2008 | 10 | 0.080 |
Why?
|
| Cerebral Arteries | 1 | 2008 | 18 | 0.080 |
Why?
|
| Syndrome | 1 | 2008 | 66 | 0.080 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2008 | 53 | 0.080 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2008 | 64 | 0.080 |
Why?
|
| Medulla Oblongata | 1 | 2008 | 53 | 0.080 |
Why?
|
| Patient Discharge | 2 | 2016 | 171 | 0.060 |
Why?
|
| Toes | 1 | 2021 | 16 | 0.050 |
Why?
|
| Antimanic Agents | 1 | 2021 | 1 | 0.050 |
Why?
|
| Consensus | 1 | 2021 | 70 | 0.050 |
Why?
|
| Antidepressive Agents | 1 | 2021 | 71 | 0.050 |
Why?
|
| Editorial Policies | 1 | 2020 | 12 | 0.050 |
Why?
|
| Quality Indicators, Health Care | 1 | 2020 | 55 | 0.040 |
Why?
|
| Brain Death | 1 | 2019 | 27 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2019 | 33 | 0.040 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 169 | 0.040 |
Why?
|
| Recurrence | 1 | 2017 | 235 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 272 | 0.030 |
Why?
|
| Hand Strength | 1 | 2016 | 90 | 0.030 |
Why?
|
| Resistance Training | 1 | 2016 | 73 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 440 | 0.030 |
Why?
|
| Mental Health | 1 | 2016 | 104 | 0.030 |
Why?
|
| Quality of Life | 1 | 2020 | 833 | 0.030 |
Why?
|
| Health Status | 1 | 2016 | 373 | 0.030 |
Why?
|
| Naturopathy | 1 | 2013 | 1 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2013 | 14 | 0.030 |
Why?
|
| Polypharmacy | 1 | 2013 | 20 | 0.030 |
Why?
|
| United States | 1 | 2021 | 3693 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2013 | 122 | 0.030 |
Why?
|
| Hepatorenal Syndrome | 1 | 2011 | 1 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2011 | 79 | 0.020 |
Why?
|
| Necrosis | 1 | 2011 | 53 | 0.020 |
Why?
|
| Shock, Septic | 1 | 2011 | 29 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2011 | 89 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2010 | 38 | 0.020 |
Why?
|
| Missouri | 1 | 2010 | 12 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 2046 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 3128 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 275 | 0.020 |
Why?
|
| Disease Progression | 1 | 2010 | 574 | 0.020 |
Why?
|
| Risk Factors | 1 | 2013 | 3600 | 0.020 |
Why?
|
| Adolescent | 1 | 2010 | 3284 | 0.010 |
Why?
|